Delivery Order SPE2DE24DA011-SPE2D625F7T10

Award Date 3/19/25
Potential Completion Date 3/25/25
Potential Value $1.6K
Federal Agency
Medical Supply Chain
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Fixed Price with Economic Price Adjustment
Place of Performance
Naples, FL 34108, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. government's Defense Logistics Agency (DLA) awarded a Delivery Order contract to Arthrex Inc., a global leader in minimally invasive orthopedic products and procedures, for the supply of an LNT Implant System with a 3.9 BC Swivelock. The contract, valued at $4,049.36, was awarded on October 23, 2024, with an ultimate completion date of October 28, 2024. Arthrex, a for-profit Subchapter S Corporation, has a significant Indefinite Delivery Contract (IDC) with the DLA, valued at...
This is a federal contract award from the Defense Logistics Agency's Medical Supply Chain to Arthrex Inc., a global leader in minimally invasive orthopedic medical technologies. The contract, valued at $2,185.39, is for the delivery of an LNT IMPLANT SYSTEM, 3.9 BC SWIVELOCK. It is a fixed-price with economic price adjustment delivery order contract with a completion date of February 24, 2025. The contract is not set aside and covers the provision of specialized orthopedic products and...
This federal contract award was made by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Arthrex Inc., a global leader in minimally invasive orthopedic products and procedures. The $9,884.85 fixed-price delivery order with economic price adjustment was awarded on November 26, 2024, with a completion date of December 2, 2024. The contract is for the supply of an LNT Implant System, 4.75 BC KL Swivelock, a specialized orthopedic implant. Arthrex, a for-profit Subchapter S...
This federal contract award is for the delivery of an LNT IMPLANT SYSTEM, 4.75 BC SWIVELOCK product to the Medical Supply Chain, a component of the Defense Logistics Agency. The fixed-price contract with economic price adjustment was awarded to Arthrex Inc., a global leader in minimally invasive orthopedic products and procedures, headquartered in Naples, Florida. The contract has a ceiling value of $6,609.38 and a completion date of December 12, 2024. This award is not designated as a set-aside...
The U.S. Defense Logistics Agency (DLA) awarded a Fixed Price with Economic Price Adjustment delivery order contract, valued at $3,509.88, to Arthrex Inc., a global leader in minimally invasive orthopedic medical technologies. The contract is for the supply of an "IMPLANT SYSTEM, SUTURELOC" and has a completion date of February 6, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Arthrex and DLA, valued at $471,048,172.66, which allows VA...
This federal contract award from the Defense Logistics Agency's Medical Supply Chain is for the delivery of the LNT IMPLANT SYSTEM, 4.75 BC SWIVELOCK medical devices. The contract, valued at $1,189.45, was awarded to Arthrex Inc., a global leader in minimally invasive orthopedic medical technologies. The contract has a fixed price with economic price adjustment pricing type and an ultimate completion date of January 29, 2025. Arthrex, a for-profit Subchapter S Corporation, has demonstrated...
This federal contract award, valued at $18,077.99, was made by the Defense Logistics Agency (DLA) Troop Support Medical to Arthrex Inc., a global leader in minimally invasive orthopedic products and procedures. The contract is for the delivery of the LNT IMPLANT SYSTEM, 4.75 BC SWIVELOCK, a surgical implant used in orthopedic procedures. The contract, which does not have a set-aside designation, is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $192 million over ten...
This federal contract, awarded by the Defense Logistics Agency's Medical Supply Chain, is for the delivery of the LNT IMPLANT SYSTEM, 3.9 BC SWIVELOCK medical device to the Department of Defense. The contract, valued at $2,774.77, was awarded to Arthrex Inc., a global leader in minimally invasive orthopedic medical technologies. Arthrex is a for-profit Subchapter S Corporation headquartered in Naples, Florida. The contract is a Delivery Order with a Fixed Price with Economic Price Adjustment...
This is a federal contract award to Arthrex Inc., a global leader in minimally invasive orthopedic products and procedures, for the delivery of an LNT IMPLANT SYSTEM, 3.9 BC SWIVELOCK. The contract, valued at $8,258.92, was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense, and has an ultimate completion date of April 10, 2024. The contract is a Delivery Order with a Fixed Price with Economic Price Adjustment pricing type. It is not...
This federal contract award to Arthrex Inc., a global leader in minimally invasive orthopedic products and procedures, was issued by the Defense Logistics Agency's (DLA) Medical Supply Chain. The $2,971.50 delivery order contract is for the supply of a bio-composite P-Lock device used in orthopedic procedures. The contract is a fixed-price with economic price adjustment and has an ultimate completion date of October 31, 2024. This delivery order is part of a larger, single-award Indefinite...
  • SPE2DE24DA011
    Indefinite Delivery Contract
  • SPE2DE24DA011-SPE2D625F7T10
    Delivery Order

This federal contract award is for the delivery of the LNT IMPLANT SYSTEM, 3.9 BC SWIVELOCK, a specialized orthopedic medical device, to the Medical Supply Chain of the Defense Logistics Agency (DLA). The contract, valued at $1,568.54, was awarded to Arthrex Inc., a global leader in minimally invasive orthopedic medical technologies. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the DLA, identified as SPE2DE24D0020, valued at $471,048,172.66 and running from June 11, 2024, to September 1, 2029. This IDC allows VA medical centers nationwide to acquire Arthrex's innovative orthopedic technologies through task orders. The contract has no set-aside designation, indicating Arthrex's strong competitive position in the federal marketplace. The contract is a Fixed Price with Economic Price Adjustment arrangement, with a completion date of March 25, 2025.

Generated 6/18/25, 11:21 AM